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Abstract
Background: Enteric fever is an endemic problem in Nepal and Widal agglutination test is widely
used for its diagnosis but a normal baseline titer in healthy population and cutoff values have not
been established.
Methods:  We measured average baseline antibody titers against "O" and "H" antigens of
Salmonella enterica serotype Typhi and "H" antigens of serotypes Paratyphi A and Paratyphi B among
apparently healthy blood donors in Nepal. The antibody titers were measured using Standard
Widal Confirmatory Quantitative Tube test.
Results: Among the 100 blood samples collected from healthy volunteers, 62 individuals had
significant antibody titers (≥ 1:20) against one of the four antigens against S. enterica. Among 54
samples with an anti-O titer against serotype Typhi, 15 and 36 samples had titers of ≥ 1:60 and ≥
1:40, respectively. A significant proportion (12% of all) had anti-O titer of ≥ 1:80. Similarly, among
the 59 samples demonstrating anti-H titers of ≥ 1:20 to S. enterica serotype Typhi, 29 had a titer of
≥ 1:80 and 12 had 1:160. For S. enterica serotypes Paratyphi A and B, anti-H titers of ≥ 1:20 were
found only in 12% and 3%, respectively, of all samples tested.
Conclusion: When a single Widal agglutination titer is used for the diagnosis of enteric fever, it
will be more appropriate to change the currently used cutoff levels against S. enterica serotype Typhi
to > 1:80 for anti-O and > 1:160 for anti-H titers for Nepal.
Background
Enteric fever continues to be a major health problem in
developing countries. In Nepal, Salmonella enterica sero-
types Typhi and Salmonella enterica serotype Paratyphi A are
common causative organisms for typhoid and paraty-
phoid fevers, respectively, whereas serotype Paratyphi B is
rare [1-3]. Enteric fever afflicts the local people as well as
the travelers to the endemic areas. The incidence of enteric
fever is higher in rainy seasons as a result of flooding and
water pollution with fecal materials [4].
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Definitive diagnosis of enteric fever depends on isolation
of salmonellae from blood, stool, urine, bone marrow,
bile or other body fluids [5-7]. However, it is a relatively
costly method and is not always available in less devel-
oped countries such as Nepal. Widal agglutination test is
an alternative laboratory test widely used for serological
diagnosis of enteric fever in these settings. Developed by
Georges Fernand Isidore Widal in 1896 to aid in the diag-
nosis of typhoid fever, Widal test utilizes a suspension of
killed Salmonella enterica as antigen to detect typhoid fever
in serum of patients with suspected enteric fever [8,9]. The
test is based on demonstration of the presence of aggluti-
nin (antibody) in the serum of an infected patient, against
the H (flagellar) and O (somatic) antigens of Salmonella
enterica serotype typhi, paratyphi A and paratyphi B, during
the acute and convalescent period of infection [10]. Usu-
ally up to 70% of adults show an early rise of antibody
titer in the first week of infection [11].
Antibody titer may be high in healthy individuals in the
presence of cross reacting antigens, such as malaria, bru-
cellosis, dengue fever, healthy carrier state, chronic liver
disease, endocarditis or other enterobacteriaceae infec-
tions [12]. There are more than 40 cross-reacting antigens
between S. typhi and other enterobacteriaceae [13]. Per-
sons who had past enteric infection or vaccinated with the
old typhoid vaccine (TAB) may develop transient anam-
nestic reaction during an unrelated febrile illnesses, such
as malaria [14]. Epidemiology of cross-reacting antigens
determines the baseline titer of Widal test as antibody pro-
duced in these diseases may cross-react with Salmonella
antigens. Therefore, a four fold rise in antibody titers
between acute and convalescent phases is considered as a
significant change in a given person. Since this type of
comparison is not practically helpful in establishing diag-
nosis of an acute illness, a single cutoff value is widely
used. In a given population, interpretation of a single
Widal test result needs to be based on average baseline
titer among the healthy individuals. Antibody titers
beyond a cut off value should be regarded as significantly
elevated titers which may be used for diagnosis in an
appropriate clinical stetting.
Normal baseline titers of Widal agglutination test for
healthy individuals and cutoff values for diagnosis of
enteric fever in Nepal have not been established. This
project was designed to determine the baseline popula-
tion antibody titers. The secondary objective was to calcu-
late minimum titers required to make diagnosis of
typhoid and paratyphoid fever in Nepal.
Methods
This study was conducted at Tribhuvan University Teach-
ing Hospital (TUTH), which is a tertiary care and aca-
demic center of 450 beds located in Kathmandu, Nepal.
This hospital's microbiology laboratory also provides
service as a referral center for many other clinics in the
Kathmandu valley and other parts of Nepal.
The objective of this project was to determine the average
baseline antibody titer against Salmonella enterica among
the apparently healthy people of Kathmandu valley.
Blood samples were collected from the blood donation
program organized by local youth club in association with
TUTH Blood Bank Department. Health screening of the
volunteer donors was done using survey questionnaires.
All the donors were apparently healthy. Individuals with
an active infection or a recent infection including tubercu-
losis, hepatitis, enteric fever, malaria or HIV/AIDS were
excluded.
Total 135 units of blood were collected from 135 appar-
ently healthy individuals and 100 bags were randomly
selected to collect blood for the study. About 2.0 ml of
blood was taken from the tubes of each bag that were not
diluted by CPDA 1 present inside the blood bags. Serum
was separated immediately, labeled and stored in at -
20°C for further processing.
The serum samples were processed according to standard
tube dilution method. Antigen suspensions of Salmonella
enterica serotypes typhi, paratyphi A and B in normal saline
were used for the Confirmatory Quantitative Tube Test.
The "O" and "H" antigens were stabilized suspensions of
smooth, non-fimbriate, killed bacilli, which were stand-
ardized to produce appropriate reactivity. When the
colored, smooth attenuated antigen suspensions were
mixed and incubated with individual's serum, anti-salmo-
nella antibodies present in the serum react with the corre-
sponding antigens to give agglutination. The "O" antigen
being a somatic antigen brings about a coarse, compact,
granular agglutination whereas "H" antigen being a flagel-
lar antigen brings about larger, loose, fluffy agglutination
[15,16]. The IgM somatic "O" antibody appears first and
represents the initial serologic response in acute typhoid
fever, while the IgG flagellar "H" antibody usually devel-
ops more slowly but persists for longer.
All the serum samples were first diluted in 1:20 ratio with
isotonic normal saline (8.5 g/liter) in such a way that final
volume contained a total of 1 ml. For each sample four
dilutions were made in four test tubes. Similarly, the
polyspecific control was also diluted in the same manner.
Then one drop (0.03 ml) each of the antigen suspensions
was added to corresponding tubes. All tubes were mixed
well and incubated at 37°C overnight (16–20 hours).
Next day, each tube was observed for the agglutination.
The test results were scored as following: 0 (no agglutina-
tion), 1 + (25% agglutination), 2+ (50% agglutination),Annals of Clinical Microbiology and Antimicrobials 2009, 8:1 http://www.ann-clinmicrob.com/content/8/1/1
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3+ (75% agglutination) and 4+ (100% agglutination)
[17]. For visualization and test to be assumed as positive,
there should be at least 50% agglutination. Initial positive
screening tests were further diluted for the determination
of the strength of antibodies. Weakly reactive agglutina-
tions required an adequate light source for proper visual-
ization.
According to World Health Organization, Regional Office
for South-East Asia, dilution should begin with 1:10 and
doubled through 1:320 or so, and 0.5 ml of antigen sus-
pension should be mixed with 0.5 ml of serum for dilu-
tion [18]. As there was a great gap between the two
dilutions, the positive samples were diluted further at the
interval of 20 and only 0.03 ml of antigen suspension was
used according to Ranbaxy Fine Chemical Limited Diag-
nostic Division, India and Tulip Diagnostics (P) Ltd,
India. For quality control, the positive polyspecific control
was also processed in the same dilutions as the test sam-
ple. Similarly normal saline was used for a negative con-
trol. Positive serum samples were diluted for each
antibody as described before.
Finally, the maximum dilution that exhibits 2+ or 50%
agglutination was considered as the end point of serum
activity and recorded as the titer of antibodies present in
the individuals against salmonella [17].
Results
A total of 100 blood samples were collected from appar-
ently healthy persons from Kathmandu valley from July to
August 2006. Samples were collected from apparently
healthy individuals of different age groups from 18 to 50
years. As very few females donated blood, only 14 blood
samples were collected from women. All the individuals
were from different places of Kathmandu valley which has
three cities-Kathmandu, Patan and Bhaktapur (Table 1).
None of the volunteers had a history of recent infections,
including malaria, viral hepatitis, tuberculosis, HIV infec-
tion, sexually transmitted diseases, or other infectious dis-
eases. They were also excluded for any active cardiac, lung
or kidney diseases.
The antibody titers against various Salmonella enterica
serotypes were determined on the separated serum by
Standard Widal Confirmatory Tube method. Among the
total 100 samples tested, 62 samples showed agglutina-
tion at the titer ≥ 1:20 for the O or H antibodies against
Salmonella enterica serotypes Typhi, Paratyphi A or Paratyphi
B (Figure 1). Rest of the 38 samples did not show aggluti-
nation. The distribution of individual antibodies with
positive titers (≥ 1:20) was as shown in Table 2.
The distribution of 54 samples with an anti-O titer of ≥
1:20 to Salmonella enterica serotype Typhi showed that a
significant proportion of the samples (15% of all samples
tested) had a titer ≥ 1:60 while more than 1/3rd (36% of
all samples) had a titer of ≥ 1:40 (Figure 2). Of note, a sig-
nificant proportion of blood samples (12 individuals)
had an anti-O titer of 1:80. The median and mean anti-
body titers against the "O" antigen were 1:20 and 1:30
(standard deviation ≥ 1:30).
Similarly, among the 59 samples showing anti-H titer of ≥
1:20 to Salmonella enterica serotype Typhi, 29 of samples
were positive at a titer of ≥ 1:80 and 12 had a titer of
1:160. The highest titer of 1:1120 was found in one sam-
ple (Figure 3). The median and mean antibody titers
against the "H" antigen were 1:20 and 1:64 (standard
deviation = 1:123).
Altogether 12 samples showed agglutination titer of ≥
1:20 against H-antigen of Salmonella enterica serotype
Paratyphi A among which 8 samples had ≥ 1:40 and 1 had
≥ 1:80 titers (Figure 4). The median and mean antibody
Table 1: Demographic table showing distribution of individuals 
according to age group, sex and city
Frequency Percentage
Total no. of individuals 100 100%
Age groups:
< 20 years 11 11%
20–30 years 66 66%
31–40 years 19 19%
41–50 years 4 4%
Gender:
Male 86 86%
Female 14 14%
Cities:
Kathmandu 89 89%
Patan 6 6%
Bhaktapur 5 5%
Table 2: Distribution of the samples with antibody titer ≥ 1:20 
against different serotypes of Salmonella enterica (Total number 
of samples, N = 100)
Serotype Antibody Type Frequency Percentage
Typhi Anti-O antigen 54 54%
Typhi Anti-H antigen 59 59%
Paratyphi A Anti-H antigen 12 12%
Paratyphi B Anti-H antigen 3 3%Annals of Clinical Microbiology and Antimicrobials 2009, 8:1 http://www.ann-clinmicrob.com/content/8/1/1
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titers against the "H" antigen of serotype Paratyphi A were
1:10 and 1:13 (standard deviation = 1:10).
Only 3 samples had anti-H titer of ≥ 1:20 to H-antigen of
Salmonella enterica serotype Paratyphi B.
Discussion
Although preferred laboratory procedure for identifica-
tion of Salmonella enterica is culture, most clinics and hos-
pitals in developing countries do not have ready access to
this method. Widal agglutination tests are widely used in
many developing countries, including Nepal, as an alter-
native laboratory procedure for diagnosis of enteric fever.
This is the first study done in Nepal which was designed
to determine the average baseline antibody titer in healthy
individuals against various serotypes of S. enterica using
the Widal test. This study showed that varying amount of
antibody against Salmonella enterica is present in healthy
individuals. A significant proportion of healthy individu-
als had high titers indicating a need of reevaluation of the
current cutoff values for diagnostic titer.
In acute typhoid fever, a rise in the anti-O antibody titer
followed by a gradual elevation of anti-H antibody titer
occurs. The anti-H antibody response persists longer than
the anti-O antibody [19,20]. The result of our study con-
firmed the presence of high agglutinin titers even in a sig-
nificant proportion of healthy individuals. We found that
15% of these samples had anti-O antibody titers of ≥ 1:80
and 16% had anti-H antibody titers of ≥ 1:160 against Sal-
monella enterica serotype Typhi. In Nepal, the current refer-
ence baseline titer of Widal agglutination test for
diagnosis of typhoid fever is 1:80 for both O & H aggluti-
nins. Therefore, the levels of agglutinins for Salmonella
typhi in these healthy individuals were greater than those
used to diagnose typhoid fever currently in Nepal. Accord-
ing to these results, significant titers should be greater
than 1:80 for anti-O and greater than 1:160 for anti-H for
a presumptive diagnosis of typhoid fever. The latter titers
are similar to what has been reported from India [21].
Similarly, a study in Vietnam found that using Widal test
cutoff titers of ≥ 1:200 for O agglutinin or ≥ 1:100 for H
agglutinin correct diagnosis was established in 74% of the
blood culture positive cases of typhoid fever [13]. Other
studies also reported that a cutoff value of anti-O titer ≥
1:160 using Widal agglutination test was more predictive
of Salmonella enterica infection [22,23]. It also appeared
that anti-H titer was more useful than anti-O titer [23].
Proper hygiene and sanitation is the main cause of low
prevalence of enteric fever in developed countries, result-
ing low antibody titer. A study in Singapore showed that
all the patients with non-typhoid fever had an anti-O
agglutinin titer of less than 1:40, while 82% had an anti-
H agglutinin of less than 1:40 [24]. They found that
typhoid patients with titers ≥ 1:40 for O and H antigens of
Salmonella typhi were significantly different from those
from non-typhoid fever. It concluded that the baseline
titer for Widal test is lesser in developed countries than in
developing countries.
Proportions of samples with antibody titers < 1:20 vs. ≥ 1:20 (N = 100) Figure 1
Proportions of samples with antibody titers < 1:20 vs. ≥ 1:20 (N = 100).
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Distribution of 54 samples with anti-O titer ≥ 1:20 against Salmonella enterica serotype Typhi Figure 2
Distribution of 54 samples with anti-O titer ≥ 1:20 against Salmonella enterica serotype Typhi.
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Distribution of 59 samples with anti-H titer ≥ 1:20 for Salmonella enterica serotype Typhi Figure 3
Distribution of 59 samples with anti-H titer ≥ 1:20 for Salmonella enterica serotype Typhi.
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In our study, the maximum anti-O and anti-H titers
against S. enterica typhi were 1:160 & 1:1120 in 2% and
1%, respectively, which may be due to other recent acute
infections. In a case report of a patient with Salmonellla
javiana in stool, the Widal reaction to typhoid "O" antigen
was 1:320 which increased to 1:20,480 by fourth day after
admission. Although initially suspected to have enteric
fever, the patient's blood and urine cultures were negative
for S. enterica [25]. Elevated levels of anti-O and anti-H
agglutinins against S. enterica have been reported in
patients with a variety other infections including those
caused by other Salmonella spp., E. coli, Klebsiella spp., and
Staphylococcus aureus [26,27]. Studies in Nigeria showed
that 85% of patients with a negative Salmonella enterica
culture but positive malaria smear had Widal titer of 1:40,
12% had titer of 1:80, and 3% had titer of 1:160 [28,29].
Our study also showed that anti-H agglutinin titer to Sal-
monella enterica serotype Paratyphi A in Kathmandu Valley
was less than that against Salmonella enterica serotype
Typhi. Only 8 individuals had anti-H titer ≥ 1:40 and only
one had a titer of 1:80. The currently used cutoff value for
anti-H titer against S. enterica serotype  Paratyphi A in
Nepal is ≥ 1:80. Only three individuals developed signifi-
cant levels of anti-H titer against Salmonella enterica sero-
type Paratyphi B, which suggests that it is a rare serotype in
Kathmandu valley.
The Widal test results may depend on the levels of anti-
bodies to cross-reacting antigens to various salmonella
species. In the Kauffmann-White classification, the genus
Salmonella issubdivided into more than 2300 serotypes
containing different combinations of antigens [30]. Sal-
monellae are divided into serological groups on the basis
of O or somatic antigens. About 60 of the 78 group D
organisms, including S. enterica serotype Typhi, and group
A and B organisms, such as S. enterica serotypes Paratyphi
A and B, also have antigen 12. Other Salmonellae share
the H (flagellar) antigens with S. enterica serotype Typhi.
Cross-reactions producing a false positive anti-O titer in
the Widal test can therefore occur with any of these sero-
types [31]. False positive Widal test results are observed in
individuals with salmonella infections other than enteric
fever, malaria, cryptococcal meningitis, immunological
disorders, and chronic liver failure. Septicemia, malaria
and dengue are other common causes of fever requiring
hospital admission which may be confused with enteric
fever because of a false positive agglutination test. These
can be differentiated from enteric fever by other appropri-
ate investigations [32,33]. Studies support that re-evalua-
Distribution of 12 samples with anti – H titer ≥ 1:20 for Salmonella enterica serotype Paratyphi A Figure 4
Distribution of 12 samples with anti – H titer ≥ 1:20 for Salmonella enterica serotype Paratyphi A.
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tion of the Widal baseline titer for healthy individuals
should be done at regular intervals [34].
Conclusion
The diagnosis of enteric fever should be established by
culture. When cultures are not available, demonstration
of a four-fold or greater rise in titer of both H and O agglu-
tinins in paired sera at an interval of 4 to 7 days is recom-
mended for serodiagnosis of enteric fever. However, a
single Widal test with higher titer may be the only method
available for presumptive diagnosis of enteric fever in
developing countries as patients usually attend hospitals
late in course of disease. In this setting, the Widal aggluti-
nation should be carefully interpreted based on the prev-
alent local baseline titer. Based on the results of this study,
we recommend to change the currently used cutoff levels
for single antibody titers against Salmonella enterica sero-
type Typhi to > 1:80 for anti-O and > 1:160 for anti-H titers
for Kathmandu valley.
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